A new DNA vaccine tested in mice significantly reduces tau and amyloid beta, two proteins implicated in Alzheimer's disease. The findings, researchers say, may pave the way for clinical trials in humans with the neurodegenerative disease.
Researchers report a new DNA vaccine prompts an immune response to proteins associated with Alzheimer's disease.
